Nivolumab + Relatlimab
Category: CancerNivolumab/relatlimab, sold under the brand name Opdualag, is a fixed-dose combination medication use to treat melanoma.[1] It contains nivolumab, a programmed death receptor-1 (PD-1) blocking antibody, and relatlimab, a lymphocyte activation gene-3 (LAG-3) blocking antibody.[1] It is given by intravenous infusion.[1] The combination was approved for medical use in the United States in March 2022.[1][2] Referenc... [wikipedia]
Related Brands
Drugs with the same active ingredientsPopular Topics
Opdivo (nivolumab) reviews
I had stage 3b subungual melanoma and after they did an amputation of my thumb and lymph nodes dissection, they lowered ...
4 REPLIESNivolumab treatments
Does anyone know of hospital in apples fl area offering immunotherapy for cancer namely nivolumab...